Get startedLog in
    Picture of Actinium Pharmaceuticals logo

    ATNM — Actinium Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapSucker Stock
    All News

    Brief: Actinium Presents Data Of Solid Tumors Treatment At SITC Conference

    Picture of Actinium Pharmaceuticals logoActinium Pharmaceuticals
    12/11/2021 13:18
    Nov 12 (Reuters) - Actinium Pharmaceuticals Inc  ATNM.A :
    * ACTINIUM PRESENTS FIRST EVER DATA WITH A CD47
IMMUNOTHERAPY IN
COMBINATION WITH A HER2-DIRECTED TARGETED RADIOTHERAPY IN SOLID
TUMORS AT THE SOCIETY FOR IMMUNOTHERAPY FOR CANCER (SITC)
CONFERENCE

Source text for Eikon:  ID:nPn74xkpYa 
Further company coverage:  ATNM.A 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Actinium Pharmaceuticals

    See all news